Cristina Müller

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 36

Top Venues

Molecular pharmaceutics

Cancers

European journal of nuclear medicine and molecular imaging

Pharmaceutics

Paul Scherrer Institute

Paul Scherrer Institute (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Paul Scherrer Institute Dec 01 2007

Switzerland

Research Group Leader :: Center for Radiopharmaceutical Sciences

Education History

Paul Scherrer Institute Apr 01 2002 - Oct 31 2005

Switzerland

PHD :: Center for Radiopharmaceutical Sciences

Publications

Rahel H Wallimann, Heloïse Hensinger, Cristina Müller, Roger Schibli, Rainer Kneuer, Patrick Schindler
Liquid Chromatography ICP-MS to Assess the Stability of 175 Lu- and nat Ga-Based Tumor-Targeting Agents towards the Development of 177 Lu- and 68 Ga-Labeled Radiopharmaceuticals. Pharmaceutics 16 (3) (2024)
Jinling Wang, Darja Beyer, Christian Vaccarin, Yingfang He, Matthias Tanriver, Roger Benoit, Xavier Deupi, Linjing Mu, Jeffrey W Bode, Roger Schibli, Cristina Müller
Development of radiofluorinated MLN-4760 derivatives for PET imaging of the SARS-CoV-2 entry receptor ACE2. European journal of nuclear medicine and molecular imaging (2024)
Rahel H Wallimann, Heloïse Hensinger, Cristina Müller, Roger Schibli, Rainer Kneuer, Patrick Schindler
Liquid Chromatography ICP-MS to Assess the Stability of 175 Lu- and nat Ga-Based Tumor-Targeting Agents towards the Development of 177 Lu- and 68 Ga-Labeled Radiopharmaceuticals. Pharmaceutics 16 (3) (2024)
Christian Vaccarin, Ana Katrina Mapanao, Luisa M Deberle, Anna E Becker, Francesca Borgna, Giovanni Marzaro, Roger Schibli, Cristina Müller
Design and Preclinical Evaluation of a Novel Prostate-Specific Membrane Antigen Radioligand Modified with a Transthyretin Binder. Cancers 16 (7) (2024)
Rahel H Wallimann, Heloïse Hensinger, Cristina Müller, Roger Schibli, Rainer Kneuer, Patrick Schindler
Liquid Chromatography ICP-MS to Assess the Stability of 175 Lu- and nat Ga-Based Tumor-Targeting Agents towards the Development of 177 Lu- and 68 Ga-Labeled Radiopharmaceuticals. Pharmaceutics 16 (3) (2024)
Christian Vaccarin, Ana Katrina Mapanao, Luisa M Deberle, Anna E Becker, Francesca Borgna, Giovanni Marzaro, Roger Schibli, Cristina Müller
Design and Preclinical Evaluation of a Novel Prostate-Specific Membrane Antigen Radioligand Modified with a Transthyretin Binder. Cancers 16 (7) (2024)
Christian Vaccarin, Ana Katrina Mapanao, Luisa M Deberle, Anna E Becker, Francesca Borgna, Giovanni Marzaro, Roger Schibli, Cristina Müller
Design and Preclinical Evaluation of a Novel Prostate-Specific Membrane Antigen Radioligand Modified with a Transthyretin Binder. Cancers 16 (7) (2024)
Sarah D Busslinger, Ana Katrina Mapanao, Kristel Kegler, Peter Bernhardt, Fabienne Flühmann, Julia Fricke, Jan Rijn Zeevaart, Ulli Köster, Nicholas P van der Meulen, Roger Schibli, Cristina Müller
Comparison of the tolerability of 161 Tb- and 177 Lu-labeled somatostatin analogues in the preclinical setting. European journal of nuclear medicine and molecular imaging (2024)
Darja Beyer, Christian Vaccarin, Xavier Deupi, Ana Katrina Mapanao, Susan Cohrs, Fan Sozzi-Guo, Pascal V Grundler, Nicholas P van der Meulen, Jinling Wang, Matthias Tanriver, Jeffrey W Bode, Roger Schibli, Cristina Müller
A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides. EJNMMI research 13 (1) (2023)
Sarah D Busslinger, Anna E Becker, Christian Vaccarin, Luisa M Deberle, Marie-Luise Renz, Viola Groehn, Roger Schibli, Cristina Müller
Investigations Using Albumin Binders to Modify the Tissue Distribution Profile of Radiopharmaceuticals Exemplified with Folate Radioconjugates. Cancers 15 (17) (2023)
Rahel H Wallimann, Patrick Schindler, Heloïse Hensinger, Viviane J Tschan, Sarah D Busslinger, Rainer Kneuer, Cristina Müller, Roger Schibli
Inductively Coupled Plasma Mass Spectrometry─A Valid Method for the Characterization of Metal Conjugates in View of the Development of Radiopharmaceuticals. Molecular pharmaceutics (2023)
Sarah D Busslinger, Viviane J Tschan, Olivia K Richard, Zeynep Talip, Roger Schibli, Cristina Müller
[ 225 Ac]Ac-SibuDAB for Targeted Alpha Therapy of Prostate Cancer: Preclinical Evaluation and Comparison with [ 225 Ac]Ac-PSMA-617. Cancers 14 (22) (2022)
Francesca Borgna, Luisa M Deberle, Sarah D Busslinger, Viviane J Tschan, Laura M Walde, Anna E Becker, Roger Schibli, Cristina Müller
Preclinical Investigations to Explore the Difference between the Diastereomers [ 177 Lu]Lu-SibuDAB and [ 177 Lu]Lu-RibuDAB toward Prostate Cancer Therapy. Molecular pharmaceutics 19 (7) (2022)
Martina Benešová, Patrycja Guzik, Luisa M Deberle, Sarah D Busslinger, Tanja Landolt, Roger Schibli, Cristina Müller
Design and Evaluation of Novel Albumin-Binding Folate Radioconjugates: Systematic Approach of Varying the Linker Entities. Molecular pharmaceutics 19 (3) (2022)
Thiago Viana Miranda Lima, Silvano Gnesin, Klaus Strobel, Maria Del Sol Pérez, Justus E Roos, Cristina Müller, Nicholas P van der Meulen
Fifty Shades of Scandium: Comparative Study of PET Capabilities Using Sc-43 and Sc-44 with Respect to Conventional Clinical Radionuclides. Diagnostics (Basel, Switzerland) 11 (10) (2021)
Luisa M Deberle, Martina Benešová, Anna E Becker, Magdalena Ratz, Patrycja Guzik, Roger Schibli, Cristina Müller
Novel Synthetic Strategies Enable the Efficient Development of Folate Conjugates for Cancer Radiotheranostics. Bioconjugate chemistry 32 (8) (2021)
Peter Bernhardt, Johanna Svensson, Jens Hemmingsson, Nicholas P van der Meulen, Jan Rijn Zeevaart, Mark W Konijnenberg, Cristina Müller, Jon Kindblom
Dosimetric Analysis of the Short-Ranged Particle Emitter 161Tb for Radionuclide Therapy of Metastatic Prostate Cancer. Cancers 13 (9) (2021)
Francesca Borgna, Patrick Barritt, Pascal V Grundler, Zeynep Talip, Susan Cohrs, Jan Rijn Zeevaart, Ulli Koester, Roger Schibli, Nicholas P van der Meulen, Cristina Müller
Simultaneous Visualization of 161Tb- and 177Lu-Labeled Somatostatin Analogues Using Dual-Isotope SPECT Imaging. Pharmaceutics 13 (4) (2021)
Viviane J Tschan, Francesca Borgna, Roger Schibli, Cristina Müller
Impact of the mouse model and molar amount of injected ligand on the tissue distribution profile of PSMA radioligands. European journal of nuclear medicine and molecular imaging (2021)
Nicholas P van der Meulen, Roger Hasler, Zeynep Talip, Pascal V Grundler, Chiara Favaretto, Christoph A Umbricht, Cristina Müller, Gaia Dellepiane, Tommaso S Carzaniga, Saverio Braccini
Developments toward the Implementation of 44Sc Production at a Medical Cyclotron. Molecules (Basel, Switzerland) 25 (20) (2020)
Nicholas P van der Meulen, Roger Hasler, Alain Blanc, Renata Farkas, Martina Benešová, Zeynep Talip, Cristina Müller, Roger Schibli
Implementation of a new separation method to produce qualitatively improved 64 Cu. Journal of labelled compounds & radiopharmaceuticals 62 (8) (2020)
Patrycja Guzik, Klaudia Siwowska, Hsin-Yu Fang, Susan Cohrs, Peter Bernhardt, Roger Schibli, Cristina Müller
Promising potential of [177Lu]Lu-DOTA-folate to enhance tumor response to immunotherapy-a preclinical study using a syngeneic breast cancer model. European journal of nuclear medicine and molecular imaging 48 (4) (2020)
Patrycja Guzik, Martina Benešová, Magdalena Ratz, Josep M Monné Rodríguez, Luisa M Deberle, Roger Schibli, Cristina Müller
Preclinical evaluation of 5-methyltetrahydrofolate-based radioconjugates-new perspectives for folate receptor-targeted radionuclide therapy. European journal of nuclear medicine and molecular imaging 48 (4) (2020)
Gwladys Nizou, Chiara Favaretto, Francesca Borgna, Pascal V Grundler, Nathalie Saffon-Merceron, Carlos Platas-Iglesias, Olivier Fougère, Olivier Rousseaux, Nicholas P van der Meulen, Cristina Müller, Maryline Beyler, Pr Raphael Tripier
Expanding the Scope of Pyclen-Picolinate Lanthanide Chelates to Potential Theranostic Applications. Inorganic chemistry 59 (16) (2020)
Cristina Müller, Roger Schibli, Britta Maurer
Can Nuclear Imaging of Activated Macrophages with Folic Acid-Based Radiotracers Serve as a Prognostic Means to Identify COVID-19 Patients at Risk? Pharmaceuticals (Basel, Switzerland) 13 (9) (2020)
Francesca Borgna, Luisa M Deberle, Susan Cohrs, Roger Schibli, Cristina Müller
Combined Application of Albumin-Binding [177Lu]Lu-PSMA-ALB-56 and Fast-Cleared PSMA Inhibitors: Optimization of the Pharmacokinetics. Molecular pharmaceutics 17 (6) (2020)
Cristina Müller, Christoph A Umbricht, Nadezda Gracheva, Viviane J Tschan, Giovanni Pellegrini, Peter Bernhardt, Jan Rijn Zeevaart, Ulli Köster, Roger Schibli, Nicholas P van der Meulen
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer. European journal of nuclear medicine and molecular imaging 46 (9) (2019)
Cristina Müller, Aviral Singh, Christoph A Umbricht, Harshad R Kulkarni, Karl Johnston, Martina Benešová, Stefan Senftleben, Dirk Müller, Christiaan Vermeulen, Roger Schibli, Ulli Köster, Nicholas P van der Meulen, Richard P Baum
Preclinical investigations and first-in-human application of 152Tb-PSMA-617 for PET/CT imaging of prostate cancer. EJNMMI research 9 (1) (2019)
Richard P Baum, Aviral Singh, Martina Benešová, Christiaan Vermeulen, Silvano Gnesin, Ulli Koester, Karl Johnston, Dirk Müller, Stefan Senftleben, Harshad V Kulkarni, Andreas Türler, Roger Schibli, John O Prior, Nicholas P van der Meulen, Cristina Müller
Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with 152Tb-DOTATOC. Dalton transactions (Cambridge, England : 2003) 46 (42) (2018)
Christoph A Umbricht, Martina Benešová, Roger Hasler, Roger Schibli, Nicholas P van der Meulen, Cristina Müller
Design and Preclinical Evaluation of an Albumin-Binding PSMA Ligand for 64Cu-Based PET Imaging. Molecular pharmaceutics 15 (12) (2018)
Christoph A Umbricht, Martina Benešová, Roger Schibli, Cristina Müller
Preclinical Development of Novel PSMA-Targeting Radioligands: Modulation of Albumin-Binding Properties To Improve Prostate Cancer Therapy. Molecular pharmaceutics 15 (6) (2018)
Martina Benešová, Christoph A Umbricht, Roger Schibli, Cristina Müller
Albumin-Binding PSMA Ligands: Optimization of the Tissue Distribution Profile. Molecular pharmaceutics 15 (3) (2018)
Janine Schniering, Francesca Borgna, Klaudia Siwowska, Martina Benešová, Susan Cohrs, Roger Hasler, Nicholas P van der Meulen, Britta Maurer, Roger Schibli, Cristina Müller
In Vivo Labeling of Plasma Proteins for Imaging of Enhanced Vascular Permeability in the Lungs. Molecular pharmaceutics 15 (11) (2018)
Silvan D Boss, Cristina Müller, Klaudia Siwowska, Josephine I Büchel, Raffaella M Schmid, Viola Groehn, Roger Schibli, Simon M Ametamey
Reduced 18F-Folate Conjugates as a New Class of PET Tracers for Folate Receptor Imaging. Bioconjugate chemistry 29 (4) (2018)
Cristina Müller, Renáta Farkas, Francesca Borgna, Raffaella M Schmid, Martina Benešová, Roger Schibli
Synthesis, Radiolabeling, and Characterization of Plasma Protein-Binding Ligands: Potential Tools for Modulation of the Pharmacokinetic Properties of (Radio)Pharmaceuticals. Bioconjugate chemistry 28 (9) (2017)
Klaudia Siwowska, Stephanie Haller, Francesca Bortoli, Martina Benešová, Viola Groehn, Peter Bernhardt, Roger Schibli, Cristina Müller
Preclinical Comparison of Albumin-Binding Radiofolates: Impact of Linker Entities on the in Vitro and in Vivo Properties. Molecular pharmaceutics 14 (2) (2017)

Cristina Müller.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Cristina Müller